Your products work on the surface. Every LED mask on the market works on the surface. But the cells that rebuild your skin — the fibroblasts that produce collagen, elastin, and structural protein — sit deeper. At 6–10mm. Below the reach of any topical. Below the reach of any consumer light device.
Until now.

Photobiomodulation (PBM) is the use of specific wavelengths of light to trigger biological responses at the cellular level. The mechanism is well-documented: photons are absorbed by chromophores within the mitochondria — primarily cytochrome c oxidase — which increases ATP production, modulates reactive oxygen species, and activates intracellular signalling pathways that regulate inflammation, proliferation, and tissue repair.

This is not a cosmetic claim. PBM is the subject of thousands of peer-reviewed studies across wound healing, dermatology, neurology, and pain management. The underlying biology is established science.

In dermatology specifically, PBM has been shown to upregulate collagen I synthesis, reduce MMP-1 (collagenase) activity, and accelerate fibroblast proliferation. The result is measurable improvement in fine lines, firmness, skin tone, and texture — outcomes documented in controlled clinical trials.

Glass GE. Photobiomodulation: the clinical applications of low-level light therapy. Aesthet Surg J. 2021;41(6):723–738.
Dompe C et al. Photobiomodulation — underlying mechanism and clinical applications. J Clin Med. 2020;9(6):1724.
Avci P et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013;32(1):41–52.

In clinical studies, over 90% of subjects showed measurable improvement in fine lines and skin texture following LED photobiomodulation.

Barolet D et al. J Invest Dermatol. 2009;129(12):2751–2759.

Light interacts with skin based on its wavelength. Shorter wavelengths (visible blue, yellow, red) are absorbed at or near the surface. Longer wavelengths in the near-infrared spectrum penetrate progressively deeper into the dermis and subcutaneous tissue.

Most consumer LED masks use one or two wavelengths — typically 630nm (red) and occasionally 830–850nm (near-infrared). These are clinically valid wavelengths. But they address a limited depth range.

ARCHER carries five.

Most research in photobiomodulation has focused on wavelengths between 600nm and 900nm. That range is well-studied, clinically validated, and used in every professional LED panel and consumer device on the market.

1072nm sits beyond that range. Published research in Archives of Dermatological Research demonstrates that 1072nm infrared light can reach more cells throughout the epidermis and dermis compared to wavelengths traditionally used in phototherapy. The physics are straightforward: longer wavelengths scatter less in tissue. 1072nm penetrates deeper.

A 2023 clinical study in Archives of Dermatological Research assessed a combination LED mask delivering 633nm, 830nm, and 1072nm for facial rejuvenation. Participants reported statistically significant improvements in skin texture, fine lines, and overall appearance, with quantitative measurements confirming the clinical observations. No adverse events were reported.

Earlier research demonstrated that 1072nm light enhanced the cutaneous immune response to bacterial infection, significantly increasing VEGF expression — a key growth factor in tissue repair and angiogenesis.

Mineroff J, Austin E, Jagdeo J. Cutaneous effects of photobiomodulation with 1072 nm light. Arch Dermatol Res. 2023;315:1481–1486. PMID: 36495337.
Lee SY et al. Enhancement of cutaneous immune response to bacterial infection after low-level light therapy with 1072 nm infrared light. J Photochem Photobiol B. 2011;105(3):175–182.
Stirling RJ, Haslam JD. A self-reported clinical trial investigates the efficacy of 1072 nm light as an anti-ageing agent. J Cosmet Laser Ther. 2007;9(4):226–230.

Every wavelength in ARCHER is selected from clinical photobiomodulation research. Below is a summary of the published evidence supporting each.

415nm — Blue
Blue light at 415nm targets C. acnes bacteria through photodynamic activation of endogenous porphyrins. The mechanism generates reactive oxygen species that destroy the bacteria responsible for inflammatory breakouts, without antibiotics or barrier disruption.

Papageorgiou P et al. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142(5):973–978. PMID: 10809858.
Goldberg DJ, Russell BA. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris. J Cosmet Laser Ther. 2006;8(2):71–75. PMID: 16766484.

590nm — Yellow
590nm yellow light has some of the strongest clinical data of any wavelength used in photobiomodulation. In a study of 90 patients, Weiss et al. reported that 90% of subjects showed visible reduction in signs of photoaging, with independent observers confirming improvement by one full Fitzpatrick wrinkle class. Biopsies revealed increased collagen density in 100% of post-treatment specimens, with a mean 28% increase in collagen I and corresponding reduction in MMP-1 (collagenase).
Separate in-vitro research has demonstrated that 590nm LED radiation attenuates UVB-induced oxidative stress in human dermal fibroblasts and restores collagen formation.

Weiss RA et al. Clinical trial of a novel non-thermal LED array for reversal of photoaging. Lasers Surg Med. 2005;37(4):291–297.
Weiss RA et al. Clinical experience with light-emitting diode (LED) photomodulation. Dermatol Surg. 2005;31(9 Pt 2):1199–1205. 900 patients.
Park KY et al. Irradiation with 590-nm yellow LED attenuates oxidative stress in UVB-damaged dermal fibroblasts. PMID: 35181944.

630nm — Red
Red light at 630nm is the most widely studied wavelength in LED phototherapy. It penetrates approximately 2mm into the dermis, targeting fibroblasts directly. Clinical trials have documented increased collagen production, reduced wrinkle depth (up to 36% reduction), and improved skin elasticity (up to 19% improvement) with no adverse effects.
A 2014 controlled trial using combined 633nm and 830nm LED reported significant increases in collagen density visible on histological evaluation, confirmed by both standard and Masson-trichrome staining.

Lee SY et al. A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation. J Photochem Photobiol B. 2007;88(1):51–67.
PMC: 10311288 — 630nm mask clinical study (collagen, wrinkle reduction).
PMC: 3926176 — Red + NIR controlled trial (collagen density, wrinkle reduction).

850nm — Near-Infrared
Near-infrared at 850nm penetrates approximately 5mm, reaching the upper dermis where fibroblast activity drives structural repair. Combined 830nm and 633nm LED therapy has been studied in randomised controlled trials, with outcomes including increased collagen and elastic fibre density, higher TIMP-1 expression (which inhibits collagen breakdown), and clinically assessed wrinkle reduction.
This is where most premium LED masks stop. ARCHER starts here and goes deeper.

Russell BA et al. A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation. J Cosmet Laser Ther. 2005;7(3–4):196–200.
Bhat J et al. A single-blinded randomised controlled study on Omnilux Revive facial treatment in skin rejuvenation. Lasers Med Sci. 2005;20(1):6–10.

1072nm — Deep Infrared (AEROARC IR™)
See Section 04 above for full evidence summary. 1072nm is ARCHER’s proprietary wavelength, delivered through AEROARC IR™ precision optics.